The health initiative Alchemy has raised $31 million. This seed investment round, totaling $31 million, was led by Andreessen Horowitz (a16z) Bio + Health. The U.S.-based Alchemy’s funding round included participation from notable investors such as Magic Johnson, Sandberg Bernthal Venture Partners, Banc of California, Twine Ventures, Springbank, and AlleyCorp.

Alchemy announced that it will use the new investment to accelerate growth, launch its own pharmacy programs across 20 states within the next year, and develop a mobile clinic program and digital platform that facilitates pharmacy operations and patient communication.

Founded in 2023 by Peter Park, Susie Crowe, and Siddarth Viswanathan, Alchemy stands out as a company implementing clinical pharmacy programs. It primarily supports clinics serving large patient populations, particularly those dealing with HIV and Hepatitis C (HCV), in establishing, operating, and developing their own in-house pharmacy programs.

The company provides the necessary physical, clinical, and digital infrastructure to set up these programs. Additionally, it plans to develop digital platforms and mobile clinic programs that streamline pharmacy operations and enhance patient communication. Their goals are to increase patient access, improve health outcomes, and enhance the financial impact clinics gain from their pharmacy programs.

By improving accessibility to healthcare, Alchemy offers critical support, especially for patients with HIV and Hepatitis C. Through its pharmacy programs, the company helps clinics enhance treatment processes, improve patient outcomes, and increase financial sustainability.


Source